Developmental neurotoxicity of ketamine in pediatric clinical use-Reference-Cited by-同舟云学术

Developmental neurotoxicity of ketamine in pediatric clinical use

Published:2013-06 Issue:1 Volume:220 Page:53-60
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Dong Chaoxuan,Anand K.J.S.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference139 articles.

1. Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial;Amr;Pain Physician,2010

2. Can adverse neonatal experiences alter brain development and subsequent behavior?;Anand;Biology of the Neonate,2000

3. Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat;Anastasio;Journal of Neurochemistry,2008

4. Recent developments in the pharmacological management of pain in children;Anderson;Current Opinion in Anaesthesiology,2006

5. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug;Aroni;Journal of Clinical Pharmacology,2009

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Ketamine for Malignant and Nonmalignant Chronic Pain in Children: A Review of Current Evidence;Journal of Pain & Palliative Care Pharmacotherapy;2023-11-27

2. Pharmacological interventions for the management of pain and discomfort during lumbar puncture in newborn infants;Cochrane Database of Systematic Reviews;2023-09-28

3. Chronic exposure to (2 R,6 R)-hydroxynorketamine induces developmental neurotoxicity in hESC-derived cerebral organoids;Journal of Hazardous Materials;2023-07

4. Twelve-year outcomes of bedside laser photocoagulation for severe retinopathy of prematurity;Frontiers in Pediatrics;2023-06-23

5. Lipoxin A4 methyl ester attenuated ketamine-induced neurotoxicity in SH-SY5Y cells via regulating leptin pathway;Toxicology in Vitro;2023-06